Chemed Company Profile (NYSE:CHE)

About Chemed (CHE)

Chemed logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: CHE
  • CUSIP: 16359R10
Key Metrics:
  • Previous Close: $185.67
  • 50 Day Moving Average: $184.04
  • 200 Day Moving Average: $163.02
  • 52-Week Range: $124.78 - $190.32
  • Trailing P/E Ratio: 28.65
  • Foreward P/E Ratio: 22.05
  • P/E Growth: 2.34
  • Market Cap: $3.03B
  • Outstanding Shares: 16,313,000
  • Beta: 1.21
  • Net Margins: 6.77%
  • Return on Equity: 23.95%
  • Return on Assets: 13.59%
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 0.79%
  • Quick Ratio: 0.76%

Analyst Ratings

Consensus Ratings for Chemed (NYSE:CHE) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $151.50 (18.50% downside)

Analysts' Ratings History for Chemed (NYSE:CHE)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/1/2016Royal Bank of CanadaReiterated RatingSector Perform$162.00 -> $148.00N/AView Rating Details
9/27/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$155.00N/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
9/15/2015Deutsche Bank AGReiterated RatingBuyN/AView Rating Details
(Data available from 4/24/2015 forward)


Earnings History for Chemed (NYSE:CHE)
Earnings by Quarter for Chemed (NYSE:CHE)
Earnings History by Quarter for Chemed (NYSE:CHE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Chemed (NYSE:CHE)
2017 EPS Consensus Estimate: $7.93
2018 EPS Consensus Estimate: $8.46
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20171$1.96$1.96$1.96
Q4 20171$2.31$2.31$2.31
Q1 20181$1.92$1.92$1.92
Q2 20181$2.03$2.03$2.03
Q3 20181$2.09$2.09$2.09
Q4 20181$2.42$2.42$2.42
(Data provided by Zacks Investment Research)


Current Dividend Information for Chemed (NYSE:CHE)
Most Recent Dividend:3/20/2017
Annual Dividend:$1.04
Dividend Yield:0.56%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:16.59% (Trailing 12 Months of Earnings)
13.16% (Based on This Year's Estimates)
12.34% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Chemed (NYSE:CHE)

Dividend History by Quarter for Chemed (NYSE:CHE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Chemed (NYSE:CHE)
Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 99.72%
Insider Trades by Quarter for Chemed (NYSE:CHE)
Institutional Ownership by Quarter for Chemed (NYSE:CHE)
Insider Trades by Quarter for Chemed (NYSE:CHE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.00View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.38View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Chemed (NYSE:CHE)
Latest Headlines for Chemed (NYSE:CHE)
DateHeadline logoChemed (CHE) Given Daily News Impact Rating of 0.31 - April 20 at 4:11 PM logoEXCLUSIVE: How Facebook fueled the Courier's stock contest leader - April 17 at 4:06 PM logoChemed (CHE) Earning Somewhat Critical News Coverage, Study Finds - April 17 at 2:54 PM logoChemed (CHE) Earns Media Impact Score of 0.50 - April 14 at 9:21 AM logoChemed (CHE) Board of Directors Initiates Share Buyback Plan - April 10 at 9:14 AM logoChemed To Report First-Quarter 2017 Earnings April 26, Related Conference Call To Be Held On April 27 - April 7 at 8:58 AM logoCHEMED CORP Files SEC form 8-K, Change in Directors or Principal Officers - April 3 at 4:40 PM logoChemed (CHE) Up 6.4% Since Earnings Report: Can It Continue? - March 21 at 8:01 AM logoChemed Corporation to Present at the Oppenheimer 27th Annual Healthcare Conference - March 15 at 4:38 PM logo8:30 am Chemed's Board authorizes an additional $100 million for stock repurchase under its existing share repurchase program - March 13 at 12:43 PM logoChemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase - March 13 at 12:43 PM logoCHEMED CORP Files SEC form 8-K, Other Events - March 13 at 12:43 PM logoCHEMED CORP Financials - March 3 at 4:17 PM logoCHEMED CORP Files SEC form 10-K, Annual Report - February 27 at 2:49 PM logoEdited Transcript of CHE earnings conference call or presentation 16-Feb-17 3:00pm GMT - February 17 at 5:56 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017 - February 17 at 5:56 PM logoCHEMED CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year - February 17 at 5:56 PM logoChemed Corporation (CHE) Reports In-Line Q4 EPS - February 16 at 4:22 PM logoChemed Corp. Profit Climbs 2% In Q4 - February 16 at 4:22 PM logoChemed's (CHE) CEO Kevin McNamara on Q4 2016 Results - Earnings Call Transcript - February 16 at 4:22 PM logoBRIEF-Chemed Q4 GAAP earnings per share $1.94 - February 16 at 4:22 PM logoChemed Corp Earnings Call scheduled for 10:00 am ET today - February 16 at 4:22 PM logoChemed Corporation to Present at the 2017 RBC Capital Markets’ Global Healthcare Conference - February 16 at 4:22 PM logoQ4 2016 Chemed Corp Earnings Release - After Market Close - February 16 at 9:55 AM logoChemed Reports Fourth-Quarter 2016 Results - February 16 at 9:55 AM logo4:19 pm Chemed beats by $0.03, misses on revs; guides FY17 EPS above consensus - February 16 at 9:55 AM logoCHEMED CORP Files SEC form 8-K, Results of Operations and Financial Condition - February 16 at 9:55 AM logoChemed posts 4Q profit - February 16 at 9:55 AM logoChemed To Report Fourth-Quarter 2016 Earnings February 15, Related Conference Call To Be Held On February 16 - January 20 at 5:25 PM logoEx-Dividend Reminder: Eli Lilly, Teleflex and Chemed - November 9 at 12:06 PM logoChemed Corporation to Present at the 2016 Credit Suisse Healthcare Conference - November 1 at 4:16 PM logoCHEMED CORP Files SEC form 10-Q, Quarterly Report - November 1 at 8:20 AM logoChemed (CHE) Lags Q3 Earnings, Tops Sales; EPS View Up - October 28 at 3:56 PM logoChemed Reports Third-Quarter 2016 Results - October 28 at 8:36 AM logoChemed's (CHE) CEO Kevin McNamara on Q3 2016 Results - Earnings Call Transcript - October 28 at 8:36 AM logoEdited Transcript of CHE earnings conference call or presentation 27-Oct-16 2:00pm GMT - October 28 at 8:36 AM logoHealthcare Earnings to Watch on Oct 26: UHS, WOOF, CHE, PRXL - October 25 at 9:01 AM logoGlobal Home Healthcare Market Outlook: 2016-2022 - September 30 at 9:14 AM


Frequently Asked Questions for Chemed (NYSE:CHE)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, February 17th. Investors of record on Monday, February 27th will be paid a dividend of $0.26 per share on Monday, March 20th. This represents a $1.04 dividend on an annualized basis and a yield of 0.56%. The ex-dividend date is Thursday, February 23rd.

How will Chemed's stock buyback program work?

Chemed declared that its board has approved a stock repurchase program on Monday, April 10th 2017, which allows the company to repurchase $100,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 3.3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) announced its earnings results on Wednesday, February, 15th. The company reported $2.10 earnings per share for the quarter, meeting the Zacks' consensus estimate of $2.10. The company had revenue of $403 million for the quarter, compared to analyst estimates of $409.89 million. Chemed had a return on equity of 23.95% and a net margin of 6.77%.

When will Chemed make its next earnings announcement?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY17 earnings guidance on Wednesday, February, 15th. The company provided earnings per share (EPS) guidance of $7.80-8.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.80.

Where is Chemed's stock going? Where will Chemed's stock price be in 2017?

3 brokers have issued 1 year price objectives for Chemed's stock. Their forecasts range from $148.00 to $155.00. On average, they expect Chemed's share price to reach $151.50 in the next year.

Who owns Chemed stock?

Chemed's stock is owned by a number of of institutional and retail investors. Top institutional investors include BTIM Corp. (1.32%), Nisa Investment Advisors LLC (0.07%), Nationwide Fund Advisors (0.07%), Boston Advisors LLC (0.06%), Louisiana State Employees Retirement System (0.04%) and Cape Cod Five Cents Savings Bank (0.03%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee.

Who sold Chemed stock? Who is selling Chemed stock?

Chemed's stock was sold by a variety of institutional investors in the last quarter, including BTIM Corp., Nationwide Fund Advisors, Bank of Montreal Can, Iowa State Bank, Nisa Investment Advisors LLC and Capstone Asset Management Co.. Company insiders that have sold Chemed stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee.

Who bought Chemed stock? Who is buying Chemed stock?

Chemed's stock was acquired by a variety of institutional investors in the last quarter, including Boston Advisors LLC, Cape Cod Five Cents Savings Bank, Private Trust Co. NA, Parametrica Management Ltd, Everence Capital Management Inc., Louisiana State Employees Retirement System and State of Alaska Department of Revenue.

How do I buy Chemed stock?

Shares of Chemed can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Chemed stock cost?

One share of Chemed stock can currently be purchased for approximately $185.89.

Chemed (CHE) Chart for Monday, April, 24, 2017

This page was last updated on 4/24/2017 by Staff